Have a feature idea you'd love to see implemented?
Let us know!
LFST LifeStance Health Group Inc
Price (delayed)
$7.01
Market cap
$2.68B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.41
Enterprise value
$3.09B
Highlights
The company's gross profit rose by 33% YoY and by 8% QoQ
The revenue has grown by 21% YoY and by 4.8% from the previous quarter
LifeStance Health Group's equity has decreased by 4.3% YoY
Key stats
What are the main financial stats of LFST
Market
Valuations
Earnings
Shares outstanding
382.62M
Market cap
$2.68B
Enterprise value
$3.09B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.87
Price to sales (P/S)
2.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.67
Revenue
$1.16B
EBIT
-$136.9M
EBITDA
-$14.7M
Free cash flow
-$17.76M
Per share
Balance sheet
Liquidity
EPS
-$0.41
Free cash flow per share
-$0.05
Book value per share
$3.74
Revenue per share
$3.05
TBVPS
$1.65
Total assets
$2.12B
Total liabilities
$689.32M
Debt
$494.4M
Equity
$1.43B
Working capital
$50.09M
Debt to equity
0.35
Current ratio
1.22
Quick ratio
1.12
Net debt/EBITDA
-27.71
Margins
Efficiency
Dividend
EBITDA margin
-1.3%
Gross margin
30.4%
Net margin
-13.1%
Operating margin
-12.1%
Return on assets
-7.1%
Return on equity
-10.5%
Return on invested capital
-16.5%
Return on capital employed
-7.2%
Return on sales
-11.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LFST stock price
How has the LifeStance Health Group stock price performed over time
Intraday
0.29%
1 week
-2.77%
1 month
1.01%
1 year
24.07%
YTD
-10.47%
QTD
0.14%
Financial performance
How have LifeStance Health Group's revenue and profit performed over time
Revenue
$1.16B
Gross profit
$352.06M
Operating income
-$139.35M
Net income
-$150.92M
Gross margin
30.4%
Net margin
-13.1%
The company's gross profit rose by 33% YoY and by 8% QoQ
The operating margin has increased by 30% year-on-year and by 22% since the previous quarter
The net margin has grown by 23% YoY and by 17% from the previous quarter
The revenue has grown by 21% YoY and by 4.8% from the previous quarter
Growth
What is LifeStance Health Group's growth rate over time
Valuation
What is LifeStance Health Group stock price valuation
P/E
N/A
P/B
1.87
P/S
2.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.67
LFST's EPS is up by 15% since the previous quarter and by 11% year-on-year
LFST's price to book (P/B) is 10% higher than its last 4 quarters average of 1.7
LifeStance Health Group's equity has decreased by 4.3% YoY
The revenue has grown by 21% YoY and by 4.8% from the previous quarter
The price to sales (P/S) is 4.5% more than the last 4 quarters average of 2.2
Efficiency
How efficient is LifeStance Health Group business performance
LFST's return on sales is up by 32% year-on-year and by 22% since the previous quarter
LFST's return on invested capital is up by 26% year-on-year and by 16% since the previous quarter
LifeStance Health Group's return on equity has increased by 12% QoQ and by 3.7% YoY
LifeStance Health Group's return on assets has increased by 12% QoQ and by 8% YoY
Dividends
What is LFST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LFST.
Financial health
How did LifeStance Health Group financials performed over time
LFST's current ratio is down by 8% YoY but it is up by 3.4% QoQ
The quick ratio has grown by 2.8% from the previous quarter
The debt is 65% less than the equity
The debt to equity has grown by 6% YoY
LifeStance Health Group's equity has decreased by 4.3% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.